Computer-Aided Drug Design & Virtual Screening Service

Screening a large compound collection experimentally is slow and expensive, and most libraries contain far more molecules than any program can test by hand. Computer-aided drug design addresses this by using the information already available about a target — its three-dimensional structure, or the compounds known to bind it — to rank and filter candidates computationally. The result is a short, reasoned list of molecules that deserve bench time, rather than an arbitrary subset of a library.

Virtual screening is most valuable where a program needs direction: an early hit-finding campaign, a target with no known ligand, or a series that must be re-focused around a new scaffold. Because the work is computational, it can be iterated quickly — a new structure or a fresh set of assay results can be folded back in within days — and it attaches a rationale to every compound it proposes. That rationale is what makes the downstream experiments interpretable instead of purely exploratory.

A frequent reason to bring this in from outside is coverage. Effective virtual screening depends on curated libraries, correctly prepared targets, and validated scoring workflows, all of which take sustained effort to build and maintain. Working with a dedicated team means the campaign is run under consistent protocols and the output arrives as ranked, annotated candidates rather than a raw score list.

What the Service Covers

• Structure-based (receptor-based) virtual screening – docking candidate molecules into a defined binding site on a known or modeled target structure, scoring their predicted fit, and selecting the best-scoring poses for follow-up.
• Ligand-based virtual screening – building pharmacophore or similarity models from compounds already known to be active, then searching a library for molecules that match that profile, which is especially useful when no usable target structure exists.
• Library and target preparation – selecting and curating the compound collection, generating candidate conformations, and preparing the binding site so that screening rests on clean inputs.

Two Screening Strategies

The choice between the two approaches depends on what is known about the target and on what the project already has in hand. They are frequently combined, with one method used to cross-check the other.

Workflow

• Define the objective – confirm the target, the biological question, and the compound space to be explored.
• Prepare the inputs – curate the library and prepare either the target structure or the reference set of actives.
• Run the screening – apply the agreed method and score the candidates under consistent settings.
• Filter and prioritize – remove unsuitable compounds, cluster related hits, and rank the remainder.
• Report – deliver a ranked candidate list with the supporting rationale and, where relevant, the predicted binding details.

Applications

• Hit finding for a new target – generate a focused set of candidates when no active compound is yet known.
• Scaffold exploration – find chemically distinct molecules that may reproduce the activity of a known series.
• Library prioritization – decide which portion of a purchased or in-house collection is worth screening first.
• Design-cycle support – evaluate proposed analogs computationally before they are made or tested.
• Pre-screening triage – reduce the number of compounds carried into experimental screening, saving cost and time.

Why Work With Us

Virtual screening is only as good as the inputs and the scrutiny behind its ranking. We prepare libraries and targets carefully, run the methods under consistent settings so results can be compared across a program, and report not just which compounds ranked highly but why. Where the computational result and the experimental evidence disagree, we flag it rather than smoothing it over, so the design decisions that follow are built on transparent reasoning.